Children with lower respiratory infections do not benefit from steroid useThe use of steroid medications for the purpose of inhibiting hospitalization or improving respiratory symptoms caused by bronchiolitis, a common viral lower respiratory infection in infants, is of no use.

This finding was revealed in a study published in an issue of The New England Journal of Medicine.

It was remarked by Nathan Kuppermann, M.D., a professor of emergency medicine and pediatrics at the University of California, Davis, chair of the PECARN network’s steering committee, and the senior investigator of the study, that the study truly highlights the power of a research network such as PECARN to find amicable answers to difficult-to-answer questions.